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Abstract
Defects in neuronal activity of the entorhinal cortex (EC) are suspected to underlie the symptoms of Alzheimer’s disease
(AD). Whereas neuroprotective effects of docosahexaenoic acid (DHA) have been described, the effects of DHA on the
physiology of EC neurons remain unexplored in animal models of AD. Here, we show that DHA consumption improved
object recognition (q12%), preventing deficits observed in old 3xTg-AD mice (Q12%). Moreover, 3xTg-AD mice displayed
seizure-like akinetic episodes, not detected in NonTg littermates and partly prevented by DHA (Q50%). Patch-clamp
recording revealed that 3xTg-AD EC neurons displayed (i) loss of cell capacitance (CC), suggesting reduced membrane
surface area; (ii) increase of firing rate versus injected current (F-I) curve associated with modified action potentials, and (iii)
overactivation of glutamatergic synapses, without changes in synaptophysin levels. DHA consumption increased CC
(q12%) and decreased F-I slopes (Q21%), thereby preventing the opposite alterations observed in 3xTg-AD mice. Our
results indicate that cognitive performance and basic physiology of EC neurons depend on DHA intake in a mouse model of
AD.
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Introduction
The loss of cognitive function is the most devastating feature of
Alzheimer’s disease (AD) and is likely to involve a dysfunction of
entorhinal-hippocampal circuitry [1,2,3,4,5]. The entorhinal
cortex (EC) and hippocampus are among the brain regions
where neurofibrillary tangles and amyloid-beta (Ab) plaques first
develop in AD patients [6,7,8,9]. Functional and anatomic
magnetic resonance imaging reveal a higher activation of
hippocampal and EC circuits in patients with mild cognitive
impairment compared to Controls, which is followed by a lower
activity in AD [10]. The loss of synapses in EC-hippocampus
network is also an important structural correlate of cognitive
decline in AD patients at an early stage [11,12]. In accordance
with human post mortem data, synapse abnormalities and Ab
deposition in these two brain regions have been reported in
animal models of Ab overexpression [13,14], whereas spontane-
ous nonconvulsive seizure activities in cortical and hippocampal
networks of young APP transgenic mice have been documented
[5,15]. The more recent triple transgenic model of AD (3xTg-
AD) also develops both neurofibrillary tangles and Ab plaques in
the EC and the hippocampus, without significant neuron loss
[16,17]. There are thus compelling arguments to hypothesize that
the activity of entorhinal and hippocampal neurons is altered
early in AD and is partly responsible for the first impairments in
cognitive function.
Beneficial effects of docosahexaenoic acid (DHA) have been
described in several transgenic animal models of AD [18,19],
including improved performancein the Morris water mazeparadigm
[20,21], prevention of the hyperphosphorylation of tau [22],
decreased Ab levels [21,22,23,24,25] and protection from the loss
of synaptic proteins [20,26]. Most epidemiological prospective studies
also support an association between higher DHA consumption and
lower risk of developing age-related dementia (see discussion). Recent
datafromclinicalassaysrevealapotentialnutraceuticalroleforDHA
in preventing or ameliorating cognitive decline [27]. However, the
effects of DHA on the physiology of cortical neurons within the EC-
hippocampus loop, which could underlie these cognitive benefits,
remain unexplored in animal models of AD.
The aim of this study was thus to investigate the beneficial
effects of DHA in 3xTg-AD mice, an animal model of AD
displaying both neurofibrillary tangles and Ab plaques [17]. To
establish functional correlates, we also studied the intrinsic and
synaptic properties of EC deep layer neurons from NonTg and
3xTg-AD mice. We selected these neurons because they are key
components of the entorhinal-hippocampal network [28,29] while
displaying a higher susceptibility to network excitation [28,30].
Our results demonstrate that DHA intake alters intrinsic and
synaptic properties of EC deep layer neurons, maintains cell
membrane surface area, ameliorates object recognition and
reduces the number of seizure-like akinetic episodes observed in
3xTg-AD mice.
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High DHA intake increased DHA and decreased
arachidonic acid (AA) concentrations in the cortex of
NonTg and 3xTg-AD mice
This study included 4 groups of 19 mice, of which 8 were used
for electrophysiological and behavioral experiments. As reported
previously [31], 3xTg-AD mice were heavier than NonTg mice
(31% for mice fed with control diet and 16% for mice fed with
high-DHA diet, P,0.001), whereas DHA intake had no effect on
animal weight (P=0.31, Table S1). Consistent with previous
reports [20,22,32], high DHA consumption induced an increase
in frontal cortex DHA of 15% in NonTg mice and of 27% in
3xTg-AD mice, compared to mice fed control diet (P,0.001,
Figure 1A and Table S1). In parallel, mice fed a high-DHA diet
had lower brain levels of AA (222% for NonTg mice and 225%
for 3xTg-AD; P,0.001, Figure 1B) and, therefore, a lower
DHA/AA ratio (44% for NonTg and 68% for 3xTg-AD,
P,0.001, Table S1). The DHA/AA ratio is important for
essential neurobiological functions like neurotransmission and the
equilibrium between PUFA metabolites involved in oxidative
stress and inflammatory response [33,34,35]. Finally, we found
Figure 1. High DHA intake modulates the fatty acid profile of the frontal cortex of NonTg and 3xTg-AD mice and decreases soluble
ptau. High DHA intake from 4 to 14 months of age increased DHA content (A) and decreased AA levels (B). (C) DHA consumption had no effect on
the level of Ab in soluble or insoluble fraction. (D) ptau was decreased in following DHA treatment, without any effect on total tau in soluble fraction
and on tau (or ptau) in insoluble fraction. Illustrations of tau/ptau and actin bands in TBS-soluble fraction (E) and tau in FAE fraction (F). Values are
expressed as mean 6 SEM. Statistical comparisons were performed using two-way ANOVA and correlations were analyzed using a linear regression.
Abbreviations: AA, arachidonic acid; DHA, docosahexaenoic acid; FA, fatty acid; FAE, formic-acid extract (insoluble fraction); iAb, insoluble Ab; itau,
insoluble tau; iptau, insoluble phospho-tau; ROD, relative optical density; sAb, soluble Ab; N, number of mice; stau, soluble tau; sptau, soluble
phospho-tau; TBS, tris-buffered saline (soluble fraction). *P,0.05, ***P,0.001.
doi:10.1371/journal.pone.0017397.g001
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(r
2=0.61, P,0.001, data not shown).
DHA treatment reduced the phosphorylation of TBS-
soluble tau with no significant effects on Ab
To determine whether DHA consumption altered the develop-
ment of tau and Ab pathologies, we quantified the concentration of
tau (Western immunoblots) and Ab (ELISA) in TBS-soluble and
detergent-insoluble fractions from brain cortex homogenates (Table
S2). We found no significant effects of DHA on Ab pathologies
(Figure 1C, Table S2), whereas DHA intake selectively decreased
phosphorylated tau (ptau) in TBS fractions (P,0.05, Figure 1D-F,
Table S2). The ptau/tau ratio was inversely correlated with the
content of DHA in the frontal cortex (r
2=0.26, P,0.05, data not
shown). No significant effect on insoluble tau was observed.
DHA improved mnesic performance deficit caused by
Ab/tau pathologies
The loss of cognitive/memory functions is the earliest devastating
feature of AD. To evaluate this in 3xTg-AD mice, we used the novel-
object recognition task. These experiments demonstrated that (1)
3xTg-AD performed significantly worse than NonTg mice (P,0.05)
and (2) the consumption of DHA improved the recognition
performance of both NonTg and 3xTg-AD mice (P,0.05)
(Figure 2A, Table S4). These observations indicate that consumption
of DHA improved the object recognition of 3xTg-AD mice, reaching
performances comparable to NonTg mice fed with control diet.
The time spent in seconds to explore the object during the first
exposition was 8863 (n=8) and 11463 (n=8) for NonTg mice
fed with control or high-DHA diet, whereas it was 7266( n = 7 )
and 7265 (n=8) for 3xTg-AD mice fed with control or high-
DHA diet. The adaptativity ratio (time spent exploring at 1 h
divided by the time spent exploring during the conditioning phase)
was 0.3360.05 (n=8) for NonTg mice fed with control diet,
0.3560.03 (n=7) for NonTg mice fed with high-DHA diet,
0.2760.05 (n=7) for 3xTg-AD mice fed with control diet and
0.2260.05 (n=8) for NonTg mice fed with high-DHA diet.
DHA partly prevented the occurrence of akinetic
episodes in 3xTg-AD mice
We next characterized the locomotor activity of animals in an
open field during 10 minutes. We observed diminished horizontal
(P,0.001) and vertical activities (P,0.001) in 3xTg-AD compared
to NonTg mice (Figure 2C-D and Table S4), without a significant
effect of DHA. The clinging test demonstrated an equal physical
performance between each group, ruling out a defect in muscular
ability as the main cause of decreased locomotor activity or
exploratory behavior (Figure 2B). However, besides these gross
alterations in locomotor activity, we observed peculiar disconti-
nuities in the behavior of 3xTg-AD mice not present in NonTg
animals. Indeed, 3xTg-AD mice exhibited frequent short episodes
of low activity. These akinetic moments occurred spontaneously
and they lasted several seconds (5–30 s). To quantify these akinetic
episodes, we fragmented our recordings of locomotor activity into
smaller, 15-sec periods and fixed two thresholds of low activity
(Figure 2E–J). Periods of less than 15 or 10 beam interruptions
were frequent in 3xTg-AD mice, strongly suggesting the
occurrence of seizure-like freezing behavior. Interestingly, DHA
intake reduced the number of akinetic episodes seen in 3xTg-AD
mice (P,0.05, low and very low activity episodes, Figure 2I–J). In
summary, our results indicate that the lower locomotor activity of
3xTg-AD mice may be explained by frequent akinetic episodes, a
defect partly prevented by chronic DHA treatment.
DHA alters passive properties of EC deep layer neurons
and prevents the decrease of CC in 3xTg-AD mice
To identify underlying functional correlates of the behavioral
effect of DHA, we next sought to determine whether DHA
treatment alter the functional properties of EC neurons within the
entorhinal-hippocampal circuitry (Figure S1). Indeed, EC neurons
transmit information to the hippocampus [29], thereby playing an
important role in memory [36,37,38]. We first studied intrinsic
properties of EC neuron using patch-clamp recording in current
clamp, focusing on passive electrophysiological parameters. We
observed that CC, an indicator of total membrane area [39,40,41],
was decreased in neurons from 3xTg-AD mice compared to
NonTg (P,0.05; Figure 3A, 3B). DHA treatment prevented this
decrease and had an overall increasing effect on CC in all animals
(P,0.05). In contrast, IR was lower in 3xTg-AD neurons (P,0.05;
Figure 3C and 3D) and higher in DHA-treated animals (P,0.05).
The flux of ions crossing the membrane via ion channels
contributes to total IR; increased movement of ions can lead to
a lower resistance. Thus, the variation of IR observed here was
likely a consequence of changes in CC since we found no
significant difference in membrane conductance (Figure 3E). The
strong correlation between IR and CC supports a tight link
between the two passive properties of EC neurons (P,0.001 and
r
2=0.36 for NonTg mice, P,0.001 and r
2=0.28 for 3xTg-AD
mice). In addition, the relationship between CC and ptau cortical
content suggests an association between tau pathology and
membrane surface atrophy (Figure 3F). Overall, these observations
strongly suggest that DHA increased the surface area of EC
neurons, preventing the decrease observed in 3xTg-AD mice.
In addition, we observed that DHA consumption led to the
hyperpolarization of EC neurons of NonTg mice (P,0.001,
Figure 3G), an effect not present in 3xTg-AD mice. Interestingly,
the resting potential inversely correlated with DHA/AA concen-
tration ratio (P,0.05, r
2=0.42, data not shown) in NonTg mice
and showed a positive relationship with TBS-soluble Ab40
(P,0.05, r
2=0.28, data not shown), TBS-soluble Ab42 (P,0.05,
r
2=0.34, data not shown) and TBS-soluble total Ab (P,0.05,
r
2=0.38, Figure 4H) in 3xTg-AD mice. Such positive relationship
in 3xTg-AD mice between resting potential and Ab concentrations
(Figure 3H) suggests that accumulation of Ab may have blocked
the hyperpolarizing effect of DHA in 3xTg-AD mice. Consistent
with a hyperpolarizing effect of DHA, we observed that the
number of spontaneously active neurons in NonTg mice fed with
DHA diet was approximately half of those from animal fed control
diet (Table S6).
Expression of transgenes, but not DHA intake, alters
action potential characteristics
To further investigate implications of DHA or APP/PS1/tau
transgenes in the physiology of entorhinal cortex deep layer
neurons, we quantified key characteristics associated with a single
action potential (Figure 4A, 4B and 4C, Table S3). Firstly, we
observed a decrease in the amplitude of action potentials (P,0.01,
Figure 4D), an increase of undershoot voltage variation (P,0.001,
Figure 4E)and a reductionof post-spike hyperpolarization(P,0.05,
Figure 4F) in 3xTg-AD neurons, compared to NonTg mice. DHA
intake had no effect on these parameters. In summary, action
potentials of 3xTg-AD EC neurons displayed important alterations.
Increased firing activity of 3xTg-AD neurons: partial
preventive effect of DHA
To characterize the effect of DHA on firing properties of EC
neurons, we next studied in current clamp two fundamental
DHA Prevents Cellular Dysfunction in AD
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of depolarization required to deliver an action potential (rheobase).
First, we found that the F-I curves were increased in 3xTg-AD
mice (P,0.001), but decreased by DHA treatment (P,0.01,
Figure 5A–C). This result indicates that firing activity of 3xTg-AD
neurons was increased compared to NonTg neurons, whereas
DHA had the opposite effects in all animals. We also found a
negative relationship between CC and F-I curves (P,0.05 and
r
2=0.01, data not shown). Second, an increase of rheobase was
detected in DHA-enriched neurons from NonTg mice (P,0.01,
Figure 5D), whereas DHA had no effect on rheobase in 3xTg-AD
animals. This is consistent with the hyperpolarizing effect of DHA
on resting potential restricted to NonTg mice presented above,
and further supported by a significant negative correlation
between both parameters (P,0.001, r
2=0.61). In summary,
DHA consumption decreased the F-I curves of EC neurons
through a CC-dependent mechanism, while Ab/tau pathologies
increased firing activity.
Functional and molecular dysfunctions of glutamatergic
synapses in 3xTg-AD mice
Cerebral hyperactivity and defective network activity were
reported in APP transgenic models of AD [5,15] and AD patients
[42,43,44]. Moreover, molecular impairments within glutamater-
gic synapses were found in AD patients and mouse models of AD
[2,20,26,45,46]. To further investigate synaptic dysfunctions in
3xTg-AD mouse, we measured the sEPSC of EC neurons. First,
we found that 3xTg-AD neurons displayed more sEPSC than
NonTg (Figure 6A–C, P,0.001), suggesting the presence of a
persistent hyperactivity of glutamatergic synapses in EC from
3xTg-AD mice and consistent with a network dysfunction.
Interestingly, DHA treatment did not prevent synaptic hyperac-
tivity of EC neurons, but rather increased the frequency of sEPSC
in all animals (Figure 6C, P,0.01). Amplitude of sEPSC was not
modulated by dietary DHA and expression of transgenes,
suggesting that the depolarizing strength of each synapse remained
unchanged for all groups (Figure 6D). The higher frequency of
sEPSC is likely be related to the ability of DHA to increase neurite
outgrowth [47] and dendritic spine density [48,49], which would
promoting synapse formation, thereby increasing detection of
sEPSC [50]. The increase of DHA-induced CC and the significant
correlation between CC and sEPSC in both genotypes support the
latter idea (Figure 6E–F, P,0.05 and r
2=0.10 for NonTg P,0.01
and r
2=0.13 for 3xTg-AD). To assess possible molecular
correlates, we quantified the level of synaptophysin and PSD95
proteins, respectively pre- and postsynaptic markers of glutama-
tergic synapses [51]. PSD-95 is involved in the regulation of the
ratio of excitatory versus inhibitory presynaptic contacts through
neuroligin-dependent pathways, suggesting that PSD-95 is in-
volved in network activity [52,53]. The apparent translocalisation
of PSD-95 from membrane to cytosolic fractions (Figure 6G)
observed here might thus be a compensatory mechanism resulting
from the hyperactivity of glutamatergic synapses. Such loss of
PSD-95 is consistent with previous analyses in the membrane
fraction from the cortex of AD patients or Tg2576 mice [20]. On
the other hand, absence of synaptophysin alteration in 3xTg-AD
mice (Figure 6H) is consistent with report on other animal model
of AD [20,54] and suggest that the rise of sEPSC was not related
to a massive change in synapses number. DHA intake had no
effect on both pre- and postsynaptic markers.
Acute application does not mimic the effect of chronic
DHA treatment
We then verified whether an acute exposure to DHA could
reproduce the effects of the chronic DHA treatment. In vitro or in
vivo data show that DHA incorporates into cell membrane
phospholipids within seconds [55,56,57]. We thus incubated brain
slices with DHA during 10 minutes followed by the same patch-
clamp experiments described above (Figure 7A–B and Table S5).
Previous studies have shown that DHA incorporates within
seconds into membrane phospholipids, where its distribution
reaches equilibrium within 10 minutes [55]. We found that acute
application of DHA did not alter the resting potential (Figure 7C),
CC (Figure 7D), input resistance (Figure 7E) or F-I curves
(Figure 7F). These experiments strongly suggest that the effects of
DHA treatment described above were not caused by binding to an
ionic receptor or by modifying membrane properties. Rather,
long-term mechanisms such as morphology alteration, gene
transcription or long-term consequence of lipid profile modifica-
tion (such as a decrease in AA and its derivatives) are likely to be
necessary to explain the chronic effect of DHA on passive and
active properties of EC deep layer neurons.
Discussion
Neuronal network dysfunction within the EC - hippocampus
loop has been hypothesized to underlie cognitive dysfunction in
AD. The results presented here indicate that EC neurons from
mice genetically programmed to develop extensive Ab and tau
pathologies display alterations of intrinsic properties consistent
with reduced membrane surface (atrophy) and show increased
neuronal activity. The effects of DHA intake on classical markers
of AD neuropathology in 3xTg-AD mice were limited to a
decrease of phosphorylated tau, in accordance with a previous
report using the same transgenic animals fed during a similar
amount of time, but with almost twice the daily dose of DHA [22].
On the other hand, DHA exerted powerful protective effects
against alterations of intrinsic properties and deterioration of
cognitive performance in 3xTg-AD mice.
Defects in intrinsic properties of EC neurons in 3xTg-AD
mice: protective effect of DHA against membrane surface
atrophy
Neuronal atrophy and reduction in synapses and/or dendrites
are well-recognized features of AD, which have been often found
in animal models as well [12,14,58,59]. Since cellular atrophy is
associated with decreased cell surface, we quantified membrane
surface area of EC neurons, using electrophysiological measure-
Figure 2. DHA prevents deficits in novel object recognition and episodes of low activity in mice 3xTg-AD. (A) Horizontal and (B) vertical
locomotor activities were both decreased in 3xTg-AD mice compared to NonTg. (C) On the object recognition task, DHA intake improved the
cognitive performance of NonTg and 3xTg-AD mice. Recognition index is represented by the percentage of time exploring the object 3 (100*object
3/total exploration during second test). (D) Forelimbs muscle tone necessary to cling onto a stretched cable was comparable between each group,
indicating that motor problems did not account for the lower activity of 3xTg-AD mice. (G) 3xTg-AD mice displayed frequent periods of low activity
(,15 beam interruptions per 15 sec) or very low activity (,10 beam interruptions per 15 sec), a feature not observed in NonTg mice (H). DHA
treatment partly prevented the occurrence of (I) low activity periods and (J) very low activity periods in 3xTg-AD mice. Statistical comparisons were
performed using two-way ANOVA or unpaired t-test (low and very low activity periods). Abbreviation: N, number of mice. P,0.05; ***P,0.001.
doi:10.1371/journal.pone.0017397.g002
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mice observed here is likely attributed to a diminution of cellular
surface. Conversely, chronic intake of DHA increased CC in all
animals, thereby fully correcting the decrease detected in 3xTg-
AD mice. Such a hypertrophic effect of DHA is in agreement with
studies reporting that DHA increases the density of synaptic spines
in vivo [48,49] and stimulated the growth of neurites in vitro [60], an
effect attributed to binding to syntaxin-3 [61]. Expected
Figure 3. Effects of DHA intake on passive properties of EC deep layer neurons from NonTg and 3xTg-AD mice. (A) CC of EC neurons
increased with DHA intake and decreased with 3xTg-AD expression. The slope of the injected current x time constant versus voltage variation plot
was used to estimate CC. Typical examples of slopes are illustrated in panel B. (C) DHA decreased, whereas 3xTg-AD transgenes increased the input
resistance following the injection of a hyperpolarized current. Input resistance was determined from the slope of the voltage variation versus injected
current plot and examples of current-voltage slope from one cell per group are illustrated in panel D. (E) Membrane conductance was not modulated
by diet or transgene expression. (F) Inverse relationship between cell capacitance and ptau in 3xTg-AD mice. (G) DHA intake hyperpolarized EC
neurons by altering their resting potential from 260 mV to 270 mV, an effect only present in NonTg mice. (H) Positive relationship between resting
potential and TBS-soluble total Ab (Ab40 + Ab42) in 3xTg-AD mice. Values are expressed as mean 6 SEM. Statistical comparisons were performed
using two-way ANOVA (CC and input resistance) and one-way ANOVA followed by Tukey-Kramer posthoc test (resting potential; variable interaction).
Correlation was performed using a linear regression. Recorded neurons were obtained from 8 mice per group. Abbreviations: CC, cell capacitance, n,
number of recorded neurons. *P,0.05; ***P,0.001.
doi:10.1371/journal.pone.0017397.g003
DHA Prevents Cellular Dysfunction in AD
PLoS ONE | www.plosone.org 6 February 2011 | Volume 6 | Issue 2 | e17397consequence of such DHA-induced morphologic modulations
would logically include enhanced glutamatergic synaptic activity
and increase sEPSC frequency as observed here in EC neurons
and reported in embryonic neuronal cultures [50]. Such increases
of CC and sEPSC frequency could lead to a better network
integration of DHA-treated neurons, enabling them to collect and
process a larger flow of information.
Neuronal hyperactivity in the 3xTg-AD mouse model:
complex action of DHA
In recent years, mounting evidence support the hypothesis that
defective neuronal activity plays an important role in the
development of symptoms in early AD [4,5,44]. Functional
magnetic resonance was used to detect an hyperactivity of EC
and hippocampus during the early stages of the disease, before full
blown neurodegeneration occurs [10]. Hyperactive episodes akin
to non-convulsive epileptic seizures were clearly demonstrated in a
mouse model of AD [5,15]. Neuronal activity and the formation of
Ab peptides are part of a vicious circle evidenced in organotypic
culture [62], whereas populations of hyperactive neurons sur-
rounding senile plaques were evidenced with calcium imaging in
animal models [63].
However,littleisknownaboutcellularmechanismsleadingtosuch
cerebral hyperactivity in AD. Our study highlights potential
mechanisms deriving from intrinsic properties of neurons. Most
importantly, an increase in firing activity was recorded in 3xTg-AD
neurons,for whichat leasttwo explanations can be proposed. On one
hand, the loss of surface area, as suggested by lower CC, is likely to
have altered current dispersion throughout the membrane of 3xTg-
AD neurons. Hence, a fixed depolarizing input produces a higher
current density and voltage variation in smaller neurons, as
schematized in Figure S2 and previously shown in modelized
motoneurons [64]. On the other hand, the action potential
modifications observed in 3xTg-AD neurons could contribute to
increase their firing rate. Indeed, the lower amplitude of action
potential recorded in 3xTg-AD EC neurons may be the results of an
increase in the voltage undershoot. Such key modifications in action
potential are known to reduce calcium-dependent potassium current
and, consequently, enhance firing activity [65,66,67,68,69]. The
reduction of post-spike hyperpolarization, a calcium-dependent
current [68,70] observed in 3xTg-AD animals, support this idea.
The effect of DHA on neuronal activity was more complex. In
NonTg animals, DHA induced hyperpolarization of EC neurons,
consistent with reported antiarrhythmic and anticonvulsant effects
of DHA [71,72,73,74,75]. Accordingly, DHA was also found to
increase the rheobase in NonTg mice. Overall, these observations
support the idea that DHA downregulates neuronal activity.
However, the effect of DHA on resting potential or rheobase were
not observed in 3xTg-AD mice. Similar alterations of resting
potential were reported in neocortical cells/dentate granule cells of
APP/PS1 mice model of AD [15] and in vitro Ab application was
known to depolarize neuron [76,77], suggesting a key role of Ab
pathology in alteration of resting potential. In addition, DHA did
reduce firing activity following sustained activation (F-I curves),
but not sufficiently to fully prevent the increase seen in 3xTg-AD
mice. Here again, altered dispersion of injected current on larger
DHA-enriched neurons is a compelling explanation for the
decreasing effect of DHA on F-I curves [64]. The correlation
between CC and F-I curves stands in agreement with this
proposition. In summary, DHA may reduce neuronal activity
through hyperpolarization of the cell membrane and by reducing
the firing activity in NonTg mice. However, these effects of DHA
Figure 4. Alteration of action potentials characteristics in 3xTg-AD mice: no effect of DHA. (A) Example of entorhinal cortex (EC) neuron
recording following an injection of a 3-s depolarizing current. In this typical trace, the injected current triggered three action potentials. (B)
Representation of a post-spike hyperpolarization (zoomed from the dashed square in A). The post-spike hyperpolarization was calculated from the
difference between the voltage undershoot after the action potential (dashed line) and the voltage peak of post-spike. (C) Representation of the
voltage undershoot following the action potential (zoomed from the dashed square in panel B). Undershoot was the difference between the
stabilized voltage after the action potential and the activation threshold. (D) Decreased amplitude was recorded in 3xTg-AD neurons, (E) increased
voltage undershoot and (F) reduced post-spike hyperpolarization of EC neurons from 3xTg-AD mice. Values are expressed as mean 6 SEM. Statistical
comparisons were performed using two-way ANOVA. Recorded neurons were obtained from 8 mice per group. Abbreviation: n, number of recorded
neurons. *P,0.05; **P,0.01; ***P,0.001.
doi:10.1371/journal.pone.0017397.g004
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fully prevent hyperactivity of EC neurons in 3xTg-AD mice.
At the synaptic level, we observed a rise of sEPSC frequency in
3xTg-AD mice, without any concurrent change in synaptic input
indexed with synaptophysin. This indicates higher spontaneous
activity of afferent excitatory synapses, consistent with EC
hyperactivity. The lower rheobase and the steeper F-I curves in
3xTg-AD neurons suggest an involvement of neuronal activity in
the observed synaptic hyperactivity. Reciprocally, synaptic hyper-
activity is known to increase glutamate-dependent conductance,
resulting in cell depolarization and an increase of F-I curves
[78,79,80,81]. Such a synergy between synaptic and intrinsic
properties may favor unrestrained brain activity and thus provides
an interesting explanation for the hyperactivation of the entorhinal-
hippocampal circuitry observed in the early stages of AD.
DHA modulates intrinsic properties of EC neurons:
cognition enhancing and antiseizure activities?
It is well known that EC neurons transmit cerebral information
to the hippocampus [29], a region strongly involved in memory
Figure 5. DHA treatment and genotype modulate active properties of EC deep layer neurons. (A, B) Examples of recording trace showing
voltage response to a 3-s depolarizing current at the excitation threshold (top trace) and 8065 pA above the rheobase (bottom trace) from the same
neuron of each group. The robust increase in firing frequency detected in 3xTg-AD mice was partly prevented by DHA, which decreased firing
frequency in all animals. The relationship between firing rate and injected current (F-I curves) from NonTg or 3xTg-AD neurons were illustrated in the
graph at the right of the panel. (C) The steepness of F-I slopes was reduced by DHA intake whereas it was increased by transgene expression. (D) DHA
intake increased rheobase only in NonTg mice. Abbreviations: F-I, firing rate versus injected current. Values are expressed as mean 6 SEM. Statistical
comparisons were performed using two-way ANOVA (F-I curves) and one-way ANOVA followed by Tukey-Kramer posthoc test (rheobase; variable
interaction). Recorded neurons were obtained from 8 mice per group. Abbreviation: n, number of recorded neurons. **P,0.01; *** P,0.001.
doi:10.1371/journal.pone.0017397.g005
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month-old 3xTg-AD mice observed here is consistent with at least
two previous reports [82,83]. Chronic dietary treatment with
DHA improved object recognition and 3xTg-AD mice treated
performed as well as NonTg animals on control diet. Such
protective action of DHA against deterioration of cognition is in
agreement with previous studies in APP mouse models of AD,
which develop only Ab pathology [20,21], and with clinical trials
on cognitive impairment associated with aging.
Indeed, recent clinical assays report improvement of cognitive
performance following n-3 PUFA intake, in cognitively normal or
individuals with mild AD or MCI [27,84,85,86], but not in
moderate or advanced AD [84,85,86,87,88,89]. In addition, our
data is consistent with most case-control and longitudinal
observational studies based on reported food consumption or
blood fatty acid measurements, which support an association
between consumption of fish and a lower risk of developing
dementia [90,91,92], although no such association was detected in
two large cohorts [93,94].
One of the most interesting observations reported here are the
frequent episodes of low activity recorded specifically in 3xTg-AD
mice. These short sequences of low activity likely have a central
origin not caused by motor deficits, as 3xTg-AD and NonTg mice
performed similarly in grip strength test. Seizure-like activity has
been previously evidenced in animal models of AD, mainly based
on EEG readouts and calbindin-D28k immunoreactivity [5,15].
These anomalies were specifically associated with abnormal
network excitability and remodeling of inhibitory circuits in the
hippocampus-cortical loop [5]. Reminiscent of the present
observations, Palop and al. reported that during EEG-confirmed
seizures, mice were immobile and subsequently resumed their
exploratory behavior [5]. The higher spontaneous activity of
excitatory synapses found in the entorhinal cortex of 3xTg-AD
mice is consistent with the contention that cerebral hyperactivity
coincides with the observed freezing behavior. Most interestingly,
chronic DHA treatment significantly reduced the occurrence of
these episodes of low activity in 3xTg-AD mice, consistent with
previous evidence of anti-seizure action of DHA [71,72,73,74,75].
Since remodeling of neuronal circuits in the hippocampus may be
instrumental in the neuronal network abnormalities seen in APP
mice [5], the regulating effect of DHA on CC and firing activity in
EC neurons may underlie its potential preventive effect of DHA
on cognitive decline and akinetic episodes observed here in the
3xTg-AD mouse.
Conclusion
In summary, our data show that 3xTg-AD mouse exhibited
poor performance in object recognition task and frequent episodes
of low activity akin to a seizure-like freezing behavior. These
cognitive defects were associated with series of alterations in
passive, active and synaptic properties of EC neurons, including (i)
reduced CC, (ii) increased firing activity and (iii) enhanced sEPSC
frequencies. Chronic treatment with DHA exerted a full, or at
least partial, preventive action against these electrophysiological
and behavioral defects, except on the basal hyperactivity of EC
neurons. Overall, our results show that chronic DHA treatment
has a direct effect on neuronal function, which is highly relevant to
its cognition-enhancing properties and potential therapeutic effects
against epilepsy and AD.
Methods
Ethics statement
The use of animals was approved by the Laval university animal
ethics committee (approval ID =07-113 and 07-061) and all
procedures were performed according to the guidelines of the
Canadian Council on Animal Care.
Animals and diets
3xTg-AD mice have been previously described [17]. Briefly, the
3xTg-AD mice express the mutated gene PS1M146V (knockin) and
mutated human genes APPSwe and tauP301L in the same locus,
both under the control of the mouse Thy1.2 regulatory element
[17]. NonTg mice were derived from the original mouse line with
the same genetic background. Only NonTg mice and homozygous
3xTg-AD were used in this study. Mice were exposed to two
isocaloric diets: (i) a control diet containing no long chain n-3
PUFA (DHA or eicosapentaenoic acid (EPA)) but 7 and
67 mmole/g of a-linolenic (LNA, 18:3 n-3) and linoleic (LA, 18:2
n-6) acid, respectively; or (ii) a high-DHA diet with 9.5, 0.5 and
34 mmole/g of DHA, LNA and LA, respectively. The n-6:n-3
PUFA ratios were of 10.4 and 2.8 in the control and high-DHA
diets. The concentration of DHA in the high-DHA diet
corresponded to a daily dose of approximately 0.6 g kg
-1 day
-1
(assuming a 25 g mouse eats 3 g of food per day). The source of
DHA was a microencapsulated formulation (MEG-3) of fish oils
from Ocean Nutrition Inc (Halifax, Canada) in order to protect
DHA molecules from oxidation [95,96,97]. MEG-3 contains a
DHA:EPA ratio of at least 4:1 both in a triglyceride form. The
main antioxidant in MEG-3 is vitamin C (5% w/w). The quantity
of vitamin C supplemented to animals treated with MEG-3
(2.25 mg/kg) is lower that vitamin C normally added in all diets
(5 mg/kg) and to vitamin C endogenously produced by the mouse.
Indeed, the mouse can synthesize endogenous vitamin C through
conversion of glucose into vitamin C in the liver by L-
gulonolactone-gamma-oxidase [98,99]. Thus, it is not even a
vitamin for the mouse and a minimal addition of vitamin C in the
diet is not expected to significantly alter their natural baseline
levels. Importantly, the two diets were exactly the same in terms of
total fat (5% w/w), total carbohydrates (66% w/w), total protein
(20% w/w), total calorie (4 kcal/g), fibers, vitamins, minerals, and
antioxidants (except for vitamin C in MEG-3). Moreover, both of
these diets did not contain phytoestrogens, which are present in
unpredictable amounts in most laboratory chows and are known
to influence the hormonal status by acting as partial estrogen
agonists [100,101]. The formula of these purified diets (produced
in collaboration with Dr Matthew Ricci from Research Diets Inc.,
New Brunswick, NJ) has been precisely determined to avoid any
Figure 6. Functional and molecular impairments of glutamatergic synapses in 3xTg-AD mice. Cellular recordings of (A) NonTg or (B)
3xTg-AD EC neurons fed with the control or high-DHA diet. (C) Transgene expression as well as DHA intake increased the frequencies of sEPSC. (D)
The mean amplitude of sEPSC did not differ between groups. CC was significantly correlated with the number of excitatory synaptic events EC
neurons from (E) NonTg and (F) 3xTg-AD mice. (G) Postsynaptic protein PSD95 was decreased in detergent-soluble fractions from 3xTg-AD mice
whereas DHA had no effect. (H) Diet and transgenes expression did not alter levels of synaptophysin, a presynaptic protein. Numbers of animals per
group for molecular experiments were 18-19, except for TBS-soluble synaptophysin (n=7–8/group). Statistical comparisons were performed using
two-way ANOVA. Correlation analyses were performed using linear regressions. Abbreviations: DS, detergent-soluble; TBS, tris-buffered saline; ROD,
relative optical density; sEPSC, spontaneous excitatory post-synaptic current. Recorded neurons were obtained from 8 mice per group. Abbreviations:
n, number of recorded neurons; N, number of mice. **P,0.01; *** P,0.001.
doi:10.1371/journal.pone.0017397.g006
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months of age and lasted until the mice were sacrificed between 12
and 14 months of age (13.261.6 months) for biochemical analysis
(up to 19 mice per group) and electrophysiological experiments (8
mice per group). This age range was chosen to avoid any
interaction with developmental or maturation processes in
younger ages and to gather endpoints at an age when Ab/tau
pathology and cognitive deficits are readily detectable. To perform
biochemical analysis, animals were perfused with PBS buffer
(pH 7.2) containing protease inhibitors (1 tablet/200 ml; Sigma,
St.Louis, MO). Brain regions were dissected from left hemisphere.
Frontal cortex (,20 mg) was used to estimate brain content of
fatty acids whereas the rest of the cortex (parietal, temporal and
occipital cortex) was pooled for biochemical measurements.
Preparation of tissue samples
After adding 8 volumes of Tris-buffered Saline (TBS) containing
Complete
TM protease inhibitors cocktail (Roche, Indianapolis,
IN), 10 mg/ml of pepstatin A, 0.1 mM EDTA and phosphatase
inhibitors (1 mM each of sodium vanadate and sodium pyrophos-
phate, 50 mM sodium fluoride), frozen samples were sonicated
briefly (3610 s) and centrifuged at 100,0006g for 20 min at 4uC
to generate a TBS-soluble intracellular and extracellular fraction
(soluble fraction). The TBS-insoluble pellet was sonicated in 5
Figure 7. Acute administration of DHA does not replicate the chronic effects of DHA treatment. (A, B) Timeline and schematic view of
DHA application experiments on EC neurons on brain slice. (C, D, E, F) In contrast to chronic oral treatment, acute DHA application on slice had no
effect on (C) resting potential, (D) CC, (E) input resistance and, (F) F-I curves. Statistical comparisons were performed using paired t-test.
Abbreviations: CC, cell capacitance; F-I, firing rate versus injected current. Recorded neurons were obtained from 5 mice. Abbreviation: n, number of
recorded neurons.
doi:10.1371/journal.pone.0017397.g007
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Triton X-100, 0.5% SDS, and 0.5% deoxycholate) containing the
same protease and phosphatase inhibitor cocktail. The resulting
homogenate was centrifuged at 100,0006g for 20 min at 4uCt o
produce a lysis buffer-soluble fraction (detergent-soluble fraction).
The pellets (detergent-insoluble fractions) were homogenized in
175 ml of 90% formic acid followed by a short sonication (3610 s).
The resultant suspension was centrifuged (15,0006 g; 4uC;
20 min) and 20 ml of the supernatant was neutralized with 1:13
dilution of Tris-base 2 M (pH 10) to be used for ELISA (see
below). The rest of the supernatant was dried out by SpeedVac
(Thermo Savant, Waltham, MA), solubilized in Laemmli’s buffer
and processed for Western immunoblotting [31].
ELISA
Insoluble Ab40 and Ab42 were measured by the Ab [1–40] and
[1–42] ELISA kits (Biosource, Camarillo, CA). Soluble Ab40 (kit
II) and Ab42 (kit high-sensitive) were measured using Human Ab
ELISA kits from WAKO (Osaka, Japan). The two ELISAs were
performed according to manufacturer’s recommendations and the
plates were read at 450 nm using a Synergy
TM HT multi-
detection microplate reader (Biotek, Winooski, VT) [31].
Western immunoblotting
For Western immunoblotting [31], protein concentration was
determined using bicinchoninic acid assays (Pierce, Rockford, IL).
Equal amounts of protein per sample (15 mg of total protein per
lane) were added to Laemmli’s loading buffer, heated to 95uC for
5 min before loading, and subjected to sodium dodecyl sulfate-
polyacrylamide gel electrophoresis. Proteins were electroblotted
onto PVDF membranes (Millipore, Billerica, MA) before blocking
in 5% nonfat dry milk and 1% bovine serum albumin (BSA) in
PBS-Tween 20 for 1 h. Membranes were immunoblotted with
appropriate primary and secondary antibodies followed by
chemiluminescence reagents (Lumiglo Reserve, KPL, Gaithers-
burg, MD). Band intensities were quantified using a KODAK
Image Station 4000 MM Digital Imaging System (Molecular
Imaging Software version 4.0.5f7, Carestream Health, Rochester,
NY). The following antibodies were used in this study: anti-actin
(ABM, Richmond, Canada), anti-CAMKII (Stressgen, Victoria,
Canada), anti-cofilin (Cell signaling technology, Boston), anti-
Drebrin (MBL International, Woburn, MA), anti-group IV iPLA2
(Santa Cruz Biotechnology, Santa Cruz, CA), anti-PAK1
(Invitrogen, Ontario, Canada), anti-PAK3 and anti-total PAK
(Cell signaling technology, Danvers, MA), anti-phospho PAK:
P141 (BioSource, Camarillo, CA), anti-PSD-95 (Millipore, Bill-
erica, MA), anti-SNAP-25 (Covance, Princeton, NJ), anti-synap-
tophysin (Millipore, Billerica, MA), anti-syntaxin 3 (Sigma, St.
Louis, MO), anti-tau-13 (Covance, Princeton, NJ), anti-tau CP13
(phosphorylated at serine 202/threonine 205, gift from Dr Peter
Davies, Albert Einstein College of Medicine, New York, NY).
Lipid extraction and gas chromatography
Since the incorporation of dietary DHA is similar in different
regions of the cortex [102,103,104,105], lipid profiles were
determined only in the frontal cortex. Experiments were
performed as previously described [31,32]. Approximately
20 mg of frozen frontal cortex from each mouse was used for
lipid extraction. Weighed brain tissues were homogenized with
BHT-Methanol (Sigma, St. Louis, MO) and two volumes of
chloroform (J.T. Baker, Phillipsburg, NJ) and 0.5 volume of
NaH2PO4 (0.2 M)-buffer solution were added to the resulting
homogenate. After centrifugation at 3500 RPM, the lower layer
(chloroform fraction) was collected [106]. Lipid extracts were
transmethylated with BF3-MeOH (Alltech, State college, PA) at
100uC for 60 min. After cooling down, 2 ml of water and 2 ml of
hexane (J.T. Baker) were added. After homogenization and
centrifugation at 3500 RPM, the upper layer (hexane fraction)
was collected, dried down to about 100 ml and transferred to a gas
chromatography autosampler vial and capped under nitrogen.
Fatty acid methyl esters in brain tissue were quantified on a model
6890 series gas chromatograph (Agilent Technologies, Palo Alto,
CA) using a FAST-GC method. One microliter of each sample
was injected at a 25:1 split ratio. Peak identification of fatty acid
methyl esters was performed by comparison to the peak retention
times of a 28-component methyl standard (Nu-Chek Prep, Elysian,
MN) [107].
Slice preparation for electrophysiology recordings
Horizontal brain slices of NonTg (8 controls and 8 high DHA)
and 3xTg-AD (8 controls and 8 high DHA) mice were prepared
from the right hemisphere as previously described [108,109].
Briefly, mice were deeply anaesthetized with ketamine (100 mg/
kg, ip) and xylazine (10 mg/kg, ip), and decapitated. The brain
was removed quickly (,60 s) and placed in an ice-cold solution
containing (mM): 210 sucrose, 3.0 KCl, 1.0 CaCl2, 3.0 MgSO4,
1.0 NaH2PO4, 26 NaHCO3 and 10 glucose, saturated with 95%
O2 and 5% CO2. Horizontal slices of 300 mm were cut from
inferior to superior brain with a vibrating tissue slicer (VT 1000 s,
Leica, Wetzlar, Germany), and kept in artificial cerebral spinal
fluid (ACSF) containing (mM): 124 NaCl, 3.0 KCl, 1.5 CaCl2, 1.3
MgCl2, 1.0 NaH2PO4, 26 NaHCO3 and 20 glucose, saturated
with 95% O2 and 5% CO2 at room temperature (21–23uC). Slices
were allowed to recover for at least 1 h before recording.
Patch-clamp recording
For recording, a slice was transferred to a submerge-type
chamber and continuously exposed to ACSF heated to 30–32uC,
saturated with 95% O2 and 5% CO2 and flowing at a rate of
2.060.2 ml/min. When mentioned, DHA (Cayman Chemical
Compagny, Michigan City, IN) at a concentration of 2 mM was
added to the extracellular solution. This concentration of DHA is
under its critical concentration for micelle formation (CMC)
[110,111,112]. DHA in solution achieves equilibrium into the
membranes phospholipid within 10 minutes [55,113] by an
adsorption mechanism [114].The slices were viewed first with a 4x
objective and deep layer of EC was located beside hippocampus
(Figure 1). In general, two slices could be recorded per
hemisphere. Large deep layer neurons in the EC were then
viewed under near-infrared illumination with a 40x water-
immersion objective (Fluor, 40x, 0.80W, Nikon, Mississauga,
ON, Canada) and a CCD camera (IR-1000, MTI, Michigan City,
IN).
Experiments were conducted at 30–32uC. Patch pipettes were
pulled from thick wall borosilicate glass (1.5/0.84 mm, WPI,
Sarasota, FL) on a horizontal puller (P-97, Sutter Instruments,
Novato, CA). The pipette solution contained (mM): 100 KMeSO4,
15 KCl, 4 ATP-Mg, 10 creatine phosphate, 10 HEPES, 0.5
EGTA (pH 7.2 with KOH). Electrodes had resistances between 2
and 5 MV. Liquid junction potential, estimated to be +5 mV, was
not corrected. The seal resistance was greater than 2 GV. Whole-
cell recordings were made at the soma with a Multiclamp 700A
amplifier (Molecular devices, Sunnyvale, CA). The serial resis-
tance, usually between 7 and 20 MV, was compensated using the
bridge balance in current-clamp and was not compensated in
voltage-clamp. Experiments were conducted using the Axograph
4.9 program (Molecular devices). Data were digitized at 8 or
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the recording protocol.
Selection of neurons and data analysis for
electrophysiology experiments
Among 186 recorded cells (49 NonTg/control, 34 NonTg/high-
DHA, 52 3xTg-AD/control, 51 3xTg-AD/high-DHA), 167
neurons had sustained spiking (41 NonTg/control, 32 NonTg/
high-DHA, 47 3xTg-AD/control, 47 3xTg-AD/high-DHA)where-
as the rest of neurons had non-sustained spiking. To study neurons
with the same electrophysiologic properties, we analyzed only
neurons having a sustained spiking. AxoGraph 4.9 and Origin 7
(OriginLab, Nothampton, MA) software programs were used for
analysis. Passive and active properties were tested in I-clamp,
whereas spontaneous excitatory postsynaptic currents (sEPSC) were
quantified in V-clamp with a voltage clamp to 260 mV. The firing
rate was estimated by counting the number of spikes during the step
and the result was plotted versus the amplitude of the injected
current (F-I graph). The slope (F-I curve) was calculated for the
firing frequencies included between 0 and 15 Hz by using linear
regression analyses. The rheobase was estimated graphically on the
F-I graph. Action potentials were detected using the event detection
package of the AxoGraph and the results were analyzed withOrigin
7. The action potential was characterized in the last 1.5 second and
the threshold was measured using a cursor, by inspecting a 5 ms
segment around the rising phase of the action potential. The input
resistance (R) was estimated from the graph slope of voltage
variation (V) versus hyperpolarizing current injection (I). The
calculation was derived from the formula ‘‘ V = R * I ’’. The
injected current duration was 400 ms and hyperpolarized current
amplitudes were 50, 100, 150 and 200 pA. The cell capacitance
(CC) wasestimatedby the formula ‘‘I * T = CC* V ’’(i.e. 1storder
RC circuit), where T is the time constant of voltage variation
(measured by fitting a single exponential function). CC corresponds
to the linear slope of the graph displaying the relationship between
‘‘ I * T ’’ and ‘‘ V ’’. We measured CC in I-clamp because this
recordingmode generatedmore accuratevaluesthanV-clamp[41].
The membrane conductance (Gm) was calculated from the resistance and CC of
the neuron using the formula ‘‘ Gm = R
21 *C C
21’’. The sEPSC were
automatically detected using the event detection package of
axograph. This package uses a pre-established template (amplitude:
5pA,rise-time:0.6 ms,decaytime:3.5 ms,baseline:1.5 ms,length:
4 ms) for detect synaptic events. Events with amplitude below 4 pA
were rejected.
Locomotor activity
Horizontal and vertical activities were monitored for 10 min at
night (complete darkness) in an automated Omnitech Digiscan
apparatus (AccuScan Instruments, Columbus, OH). The box had
a dimension of 20 cm620 cm. Horizontal activities were detected
by a set of infrared sensors ranged in XY axes while vertical
activities were detected only in the X axis. The distance between
each detector was 2.5 cm. Recordings and data processing were
made using the software VersaMax 4.20 (Molecular Devices).
Horizontal and vertical activities were expressed by the number of
beam interruptions, split in 15-s intervals. For instance, we
evaluated the number of beam interruptions for a few simple
movements: 2–4 for a head movement (left to right), 4–5 for a 90-
degree rotation and 3–6 for a 5-cm movement.
Exploration/recognition test
The object recognition task is based on the spontaneous
tendency of rodents to explore a novel object longer than a
familiar one. We opted for a non-stressful cognitive test because
3xTg-AD mice display a high anxiety level [83,115], which could
confuse the interpretation of their behavioral response in more
stressful cognitive tasks (such as the Morris water maze). During
the conditioning phase, animals were placed individually in a
standard mouse cage (29.2 cm619 cm612.7 cm) containing two
objects for a period of 10 min. The objects were comparable in
size, texture and shape complexity. The objects were either
rectangular (4 cm 64c m66 cm), cylindrical (4 cm diameter 66
cm high), conical (3.8 cm in diameter at the base and 1.8 cm in
diameter in height, 4.5 cm high) or triangular (2.5 cm per side
66.5 cm high). The test was repeated one hour later with a known
object and a new one. Object recognition was investigated after
one hour because the recognition index of our control mice was
significantly decreased after this time, thus reducing the sensitivity
of the test. The time spent exploring and sniffing each object was
recorded. The ratio of time spent exploring the new versus the
known object was used as an indicator of recognition and memory
[116,117,118,119]. Animals whose exploration was not considered
sufficient to allow recognition (20 s per item) were rejected from
the analysis.
Physical and muscular evaluation
Animals were suspended by the forelimbs to a stretched cable of
2 mm diameter, and the time mice remained clinging to the cable
was measured to assess muscular tone. Each animal underwent
two tests and the best score was kept.
Statistical Analysis
Values were expressed as mean 6 standard error of the mean
(SEM). Statistical comparisons were performed using a two-way
ANOVA for the study of two variables simultaneously. When
variable interaction was detected, statistical comparisons were
performed using a one-way ANOVA followed by Tukey-Kramer
post-hoc test. When only 2 groups were compared, statistical
comparisons were performed using an unpaired Student’s t-test.
The DHA application protocol was analyzed using paired
Student’s t-test. Correlation analyses were performed using linear
regressions. The relationship between molecular parameters (fatty
acid content, synaptic and pathologic markers) and cellular
electrophysiological parameters was calculated by attributing one
electrophysiological value par animal (corresponding to the
average of a minimum of two recording cells). Correlations
between electrophysiological parameters were carried out using
values from single neurons.
Supporting Information
Figure S1 Tissue preparation for electrophysiological
recordings. (A) Side-view of the mouse brain. The black line
represents the 300-mm horizontal section used in this study. (B)
Horizontal mouse brain section stained with haematoxylin nuclear
counterstain. Whole-cell recordings (REC) were made in deep
layer of EC. Abbreviations: CPu, caudate putamen (striatum);
Hipp, hippocampus.
(TIFF)
Figure S2 Cellular and membranous models to explain
the modulation of CC on current density and voltage
variation. (A, B) The injected current is dispersed throughout the
membrane surface. Thus, a neuron with a larger membrane
surface area will have a smaller current density, since membrane
conductance is kept constant. Consequently, this smaller current
density produces a smaller voltage variation. Mathematical
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cellular and membranous level were given in panels C and D.
Formula abbreviations: IR: input resistance (cellular resistance),
CC: cell capacitance, Gcell: cell conductance, Gm: membrane
conductance, Iinj: injected current, Im: membrane current or
current density, DV: voltage variation, <: proportional.
(TIF)
Table S1 Summary of the effects of DHA dietary treatment and
transgene expression effects on proteins, animal weight and lipid
content in the frontal cortex. Values for synaptic markers were
normalized with actin. Values are expressed as mean 6 SEM.
Statistical comparisons were performed using a two-way ANOVA
for the study of two variables simultaneously. When variable
interaction was detected, statistical comparisons were performed
using a one-way ANOVA followed by Tukey-Kramer post-hoc
test. Abbreviations: AA, arachidonic acid; CAMKII: calcium/
camodulin-dependent protein kinase II; DHA, docosahexaenoic
acid; DS: detergent-soluble (membrane fraction); TBS: Tris buffer
saline (cytosolic fraction); PAK: p21-activated kinase; PSD95:
postsynaptic density-95. *P,0.05: **P,0.01 (significantly different
of NonTg mice fed with control diet).
oP,0.05 (significantly
different of NonTg mice fed with high-DHA diet). #P,0.05
(significantly different of 3xTg-AD mice fed with control diet).
(TIF)
Table S2 Summary of DHA dietary treatment and
transgene expression effects on pathologic markers in
3xTg-AD mice. Values of tau in TBS-soluble fractions were
expressed as a ratio over actin quantified on the same blots. TBS-
soluble Ab40 and Ab42 values were expressed as picograms per
milligram of protein while FAE-Ab values were expressed as
picograms per milligram of tissue. Tau in FAE fractions was
quantified by relative optical density. Values are expressed as
mean 6 SEM and number of mice analysis is indicated between
brackets. Statistical comparisons were performed using an
unpaired Student’s t-test. Abbreviations: TBS: Tris buffer saline;
FAE: formic-acid extract (detergent-insoluble fraction). *P,0.05.
(TIF)
Table S3 Summary of electrophysiology properties of
deep layer pyramidal neurons from NonTg and 3xTg-AD
mice fed with control or high-DHA diet. Electrophysiologic
data were obtained from 8 mice per groups. Values are expressed
as mean 6 SEM and number of recorded neurons is indicated
between brackets. Statistical comparisons were performed using a
two-way ANOVA and P value was given in the right column.
When variable interaction was detected, statistical comparisons
were performed using a one-way ANOVA followed by Tukey-
Kramer posthoc test. ***P,0.001 (significantly different of other
groups).
(TIF)
Table S4 Summary of behavioral outcomes. Values are
expressed as mean 6 SEM. Statistical comparisons were
performed using a two-way ANOVA for the study of two variables
simultaneously. When variable interaction was detected, statistical
comparisons were performed using a one-way ANOVA followed
by Tukey-Kramer post-hoc test.uP,0.05 (significantly different of
3xTg-AD mice fed with high-DHA diet).
(TIF)
Table S5 Summary of the intrinsic properties of
entorhinal cortex neurons before, during and after an
application of 2 mM DHA. Electrophysiologic data were
obtained from 5 mice. Values are expressed as mean 6 SEM.
Statistical comparisons were performed using paired Student’s t-
test. Abbreviations: F-I, firing rate versus injected current.
(TIF)
Table S6 Number of spontaneously active neurons in
each group. Electrophysiologic data were obtained from 8 mice
per groups.
(TIF)
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